{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T03:08:05Z","timestamp":1779160085740,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"DOI":"10.1038\/s41398-026-04016-3","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T01:35:30Z","timestamp":1775525730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tau accumulation increases the susceptibility to effective seizures of electroconvulsive therapy"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0782-0174","authenticated-orcid":false,"given":"Tomoyuki","family":"Ohya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5569-1361","authenticated-orcid":false,"given":"Ryosuke","family":"Arakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5873-0345","authenticated-orcid":false,"given":"Takeshi","family":"Sakayori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsuyoshi","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0609-077X","authenticated-orcid":false,"given":"Shotaro","family":"Uchiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4590-0120","authenticated-orcid":false,"given":"Amane","family":"Tateno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"key":"4016_CR1","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1056\/NEJMra2034954","volume":"386","author":"RT Espinoza","year":"2022","unstructured":"Espinoza RT, Kellner CH. Electroconvulsive therapy. N. Engl. J. Med. 2022;386:667\u201372. https:\/\/doi.org\/10.1056\/NEJMra2034954.","journal-title":"N. Engl. J. Med"},{"key":"4016_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41386-023-01677-2","volume":"49","author":"ZD Deng","year":"2024","unstructured":"Deng ZD, Robins PL, Regenold W, Rohde P, Dannhauer M, Lisanby SH. How electroconvulsive therapy works in the treatment of depression: is it the seizure, the electricity, or both?. Neuropsychopharmacology. 2024;49:150\u201362. https:\/\/doi.org\/10.1038\/s41386-023-01677-2.","journal-title":"Neuropsychopharmacology"},{"key":"4016_CR3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00406-013-0420-5","volume":"264","author":"C Hoyer","year":"2014","unstructured":"Hoyer C, Kranaster L, Janke C, Sartorius A. Impact of the anesthetic agents ketamine, etomidate, thiopental, and propofol on seizure parameters and seizure quality in electroconvulsive therapy: A retrospective study. Eur. Arch. Psychiatry Clin. Neurosci. 2014;264:255\u201361. https:\/\/doi.org\/10.1007\/s00406-013-0420-5.","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci"},{"key":"4016_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1192\/bjp.2017.28","volume":"212","author":"L van Diermen","year":"2018","unstructured":"van Diermen L, van den Ameele S, Kamperman AM, Sabbe BCG, Vermeulen T, Schrijvers D, et al. Prediction of electroconvulsive therapy response and remission in major depression: meta-analysis. Br. J. Psychiatry. 2018;212:71\u201380. https:\/\/doi.org\/10.1192\/bjp.2017.28.","journal-title":"Br. J. Psychiatry"},{"key":"4016_CR5","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.3390\/ijms23084307","volume":"23","author":"M Altuna","year":"2022","unstructured":"Altuna M, Olmedo-Saura G, Carmona-Iragui M, Fortea J. Mechanisms involved in epileptogenesis in alzheimer\u2019s disease and their therapeutic implications. Int. J. Mol. Sci. 2022;23:4307 https:\/\/doi.org\/10.3390\/ijms23084307.","journal-title":"Int. J. Mol. Sci"},{"key":"4016_CR6","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1474-4422(22)00168-5","volume":"21","author":"R Ossenkoppele","year":"2022","unstructured":"Ossenkoppele R, van der Kant R, Hansson O. Tau biomarkers in Alzheimer\u2019s disease: towards implementation in clinical practice and trials. Lancet Neurol. 2022;21:726\u201334. https:\/\/doi.org\/10.1016\/S1474-4422(22)00168-5.","journal-title":"Lancet Neurol"},{"key":"4016_CR7","doi-asserted-by":"publisher","first-page":"1241638","DOI":"10.3389\/fneur.2023.1241638","volume":"14","author":"LB Hickman","year":"2023","unstructured":"Hickman LB, Stern JM, Silverman DHS, Salamon N, Vossel K. Clinical, imaging, and biomarker evidence of amyloid- and tau-related neurodegeneration in late-onset epilepsy of unknown etiology. Front. Neurol. 2023;14:1241638. https:\/\/doi.org\/10.3389\/fneur.2023.1241638.","journal-title":"Front. Neurol"},{"key":"4016_CR8","doi-asserted-by":"publisher","first-page":"903973","DOI":"10.3389\/fnagi.2022.903973","volume":"14","author":"K Hwang","year":"2022","unstructured":"Hwang K, Vaknalli RN, Addo-Osafo K, Vicente M, Vossel K. Tauopathy and epilepsy comorbidities and underlying mechanisms. Front. Aging Neurosci. 2022;14:903973 https:\/\/doi.org\/10.3389\/fnagi.2022.903973.","journal-title":"Front. Aging Neurosci"},{"key":"4016_CR9","doi-asserted-by":"publisher","first-page":"5856","DOI":"10.1038\/s41380-020-0766-9","volume":"26","author":"S Moriguchi","year":"2021","unstructured":"Moriguchi S, Takahata K, Shimada H, Kubota M, Kitamura S, Kimura Y, et al. Excess tau PET ligand retention in elderly patients with major depressive disorder. Mol. Psychiatry. 2021;26:5856\u201363. https:\/\/doi.org\/10.1038\/s41380-020-0766-9.","journal-title":"Mol. Psychiatry"},{"key":"4016_CR10","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/j.neuron.2013.07.037","volume":"79","author":"M Maruyama","year":"2013","unstructured":"Maruyama M, Shimada H, Suhara T, Shinotoh H, Ji B, Maeda J, et al. Imaging of tau pathology in a tauopathy mouse model and in Alzheimer patients compared to normal controls. Neuron. 2013;79:1094\u2013108. https:\/\/doi.org\/10.1016\/j.neuron.2013.07.037.","journal-title":"Neuron"},{"key":"4016_CR11","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.2967\/jnumed.114.139550","volume":"55","author":"H Hashimoto","year":"2014","unstructured":"Hashimoto H, Kawamura K, Igarashi N, Takei M, Fujishiro T, Aihara Y, et al. Radiosynthesis, photoisomerization, biodistribution, and metabolite analysis of 11C-PBB3 as a clinically useful PET probe for imaging of tau pathology. J. Nucl. Med. 2014;55:1532\u20138. https:\/\/doi.org\/10.2967\/jnumed.114.139550.","journal-title":"J. Nucl. Med"},{"key":"4016_CR12","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.2967\/jnumed.115.160127","volume":"56","author":"Y Kimura","year":"2015","unstructured":"Kimura Y, Ichise M, Ito H, Shimada H, Ikoma Y, Seki C, et al. PET quantification of tau pathology in human brain with 11C-PBB3. J. Nucl. Med. 2015;56:1359\u201365. https:\/\/doi.org\/10.2967\/jnumed.115.160127.","journal-title":"J. Nucl. Med"},{"key":"4016_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuron.2020.09.042","volume":"109","author":"K Tagai","year":"2021","unstructured":"Tagai K, Ono M, Kubota M, Kitamura S, Takahata K, Seki C, et al. High-Contrast in vivo imaging of tau pathologies in alzheimer\u2019s and non-alzheimer\u2019s disease tauopathies. Neuron. 2021;109:42\u201358.e8. https:\/\/doi.org\/10.1016\/j.neuron.2020.09.042.","journal-title":"Neuron"},{"key":"4016_CR14","doi-asserted-by":"publisher","first-page":"fcae075","DOI":"10.1093\/braincomms\/fcae075","volume":"6","author":"M Kubota","year":"2024","unstructured":"Kubota M, Endo H, Takahata K, Tagai K, Suzuki H, Onaya M, et al. In vivo PET classification of tau pathologies in patients with frontotemporal dementia. brain commun. Brain Commun. 2024;6:fcae075 https:\/\/doi.org\/10.1093\/braincomms\/fcae075.","journal-title":"Brain Commun"},{"key":"4016_CR15","unstructured":"Takebayashi M et. al. ECT Good Practice. The Japanese Society of Psychiatry and Neurology, ECT\/rTMS commission of Japan, editors. Shinko Igaku Publisher; 2020."},{"key":"4016_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/jlcr.3890","volume":"64","author":"K Kawamura","year":"2021","unstructured":"Kawamura K, Hashimoto H, Furutsuka K, Ohkubo T, Fujishiro T, Togashi T, et al. Radiosynthesis and quality control testing of the tau imaging positron emission tomography tracer [18 F]PM-PBB3 for clinical applications. J. Label. Comp. Radiopharm. 2021;64:109\u201319. https:\/\/doi.org\/10.1002\/jlcr.3890.","journal-title":"J. Label. Comp. Radiopharm"},{"key":"4016_CR17","doi-asserted-by":"publisher","first-page":"e209920","DOI":"10.1212\/WNL.0000000000209920","volume":"103","author":"AD Lam","year":"2024","unstructured":"Lam AD, Thibault EG, Mayblyum DV, Hsieh S, Pellerin KR, Sternberg EJ, et al. Association of seizure foci and location of tau and amyloid deposition and brain atrophy in patients with alzheimer disease and seizures. Neurology. 2024;103:e209920 https:\/\/doi.org\/10.1212\/WNL.0000000000209920.","journal-title":"Neurology"},{"key":"4016_CR18","doi-asserted-by":"publisher","first-page":"fcae327","DOI":"10.1093\/braincomms\/fcae327","volume":"6","author":"M Putra","year":"2024","unstructured":"Putra M, Rao NS, Gardner C, Liu G, Trommater J, Bunney M, et al. Enhanced Fyn-tau and NR2B-PSD95 interactions in epileptic foci in experimental models and human epilepsy. Brain Commun. 2024;6:fcae327 https:\/\/doi.org\/10.1093\/braincomms\/fcae327.","journal-title":"Brain Commun"},{"key":"4016_CR19","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.yebeh.2015.04.030","volume":"49","author":"G Monti","year":"2015","unstructured":"Monti G, Tondelli M, Giovannini G, Bedin R, Nichelli PF, Trenti T, et al. Cerebrospinal fluid tau proteins in status epilepticus. Epilepsy Behav. 2015;49:150\u20134. https:\/\/doi.org\/10.1016\/j.yebeh.2015.04.030.","journal-title":"Epilepsy Behav"},{"key":"4016_CR20","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.yebeh.2019.06.033","volume":"98","author":"M T\u00e1buas-Pereira","year":"2019","unstructured":"T\u00e1buas-Pereira M, Dur\u00e3es J, Lopes J, Sales F, Bento C, Duro D, et al. Increased CSF tau is associated with a higher risk of seizures in patients with Alzheimer\u2019s disease. Epilepsy Behav. 2019;98:207\u20139. https:\/\/doi.org\/10.1016\/j.yebeh.2019.06.033.","journal-title":"Epilepsy Behav"},{"key":"4016_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nrn2967","volume":"12","author":"LM Ittner","year":"2011","unstructured":"Ittner LM, G\u00f6tz J. Amyloid-\u03b2 and tau-a toxic pas de deux in Alzheimer\u2019s disease. Nat. Rev. Neurosci. 2011;12:65\u201372. https:\/\/doi.org\/10.1038\/nrn2967.","journal-title":"Nat. Rev. Neurosci"},{"key":"4016_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00401-015-1387-2","volume":"129","author":"DR Thal","year":"2015","unstructured":"Thal DR, F\u00e4ndrich M. Protein aggregation in Alzheimer\u2019s disease: A\u03b2 and \u03c4 and their potential roles in the pathogenesis of AD. Acta Neuropathologica. 2015;129:163\u20135. https:\/\/doi.org\/10.1007\/s00401-015-1387-2.","journal-title":"Acta Neuropathologica"},{"key":"4016_CR23","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3389\/fncel.2020.00019","volume":"14","author":"D Toral-Rios","year":"2020","unstructured":"Toral-Rios D, Pichardo-Rojas PS, Alonso-Vanegas M, Campos-Pe\u00f1a V. GSK3\u03b2 and tau protein in alzheimer\u2019s disease and epilepsy. Front. Cell Neurosci. 2020;14:19 https:\/\/doi.org\/10.3389\/fncel.2020.00019.","journal-title":"Front. Cell Neurosci"},{"key":"4016_CR24","doi-asserted-by":"publisher","first-page":"4199","DOI":"10.1021\/acschemneuro.9b00460","volume":"10","author":"YN Paudel","year":"2019","unstructured":"Paudel YN, Angelopoulou E, Jones NC, O\u2019Brien TJ, Kwan P, Piperi C, et al. Tau Related Pathways as a connecting link between epilepsy and alzheimer\u2019s disease. ACS Chem. Neurosci. 2019;10:4199\u2013212. https:\/\/doi.org\/10.1021\/acschemneuro.9b00460.","journal-title":"ACS Chem. Neurosci"},{"key":"4016_CR25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","volume":"142","author":"LM Ittner","year":"2010","unstructured":"Ittner LM, Ke YD, Delerue F, Bi M, Gladbach A, van Eersel J, et al. Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer\u2019s disease mouse models. Cell. 2010;142:387\u201397. https:\/\/doi.org\/10.1016\/j.cell.2010.06.036.","journal-title":"Cell"},{"key":"4016_CR26","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.neurobiolaging.2020.06.004","volume":"94","author":"V Gomez-Murcia","year":"2020","unstructured":"Gomez-Murcia V, Sandau U, Ferry B, Parrot S, Laurent C, Basquin M, et al. Hyperexcitability and seizures in the THY-Tau22 mouse model of tauopathy. Neurobiol. Aging. 2020;94:265\u201370. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2020.06.004.","journal-title":"Neurobiol. Aging"},{"key":"4016_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.nbd.2013.06.005","volume":"58","author":"AM Garc\u00eda-Cabrero","year":"2013","unstructured":"Garc\u00eda-Cabrero AM, Guerrero-L\u00f3pez R, Gir\u00e1ldez BG, Llorens-Mart\u00edn M, Avila J, Serratosa JM, et al. Hyperexcitability and epileptic seizures in a model of frontotemporal dementia. Neurobiol. Dis. 2013;58:200\u20138. https:\/\/doi.org\/10.1016\/j.nbd.2013.06.005.","journal-title":"Neurobiol. Dis"},{"key":"4016_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/YCT.0000000000000274","volume":"32","author":"A Minelli","year":"2016","unstructured":"Minelli A, Abate M, Zampieri E, Gainelli G, Trabucchi L, Segala M, et al. Seizure adequacy markers and the prediction of electroconvulsive therapy response. J. ECT. 2016;32:88\u201392. https:\/\/doi.org\/10.1097\/YCT.0000000000000274.","journal-title":"J. ECT"},{"key":"4016_CR29","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3233\/JAD-161247","volume":"58","author":"V Orgeta","year":"2017","unstructured":"Orgeta V, Tabet N, Nilforooshan R, Howard R. Efficacy of antidepressants for depression in alzheimer\u2019s disease: systematic review and meta-analysis. J. Alzheimers Dis. 2017;58:725\u201333. https:\/\/doi.org\/10.3233\/JAD-161247.","journal-title":"J. Alzheimers Dis"},{"key":"4016_CR30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0140-6736(11)60830-1","volume":"378","author":"S Banerjee","year":"2011","unstructured":"Banerjee S, Hellier J, Dewey M, Romeo R, Ballard C, Baldwin R, et al. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Lancet. 2011;378:403\u201311. https:\/\/doi.org\/10.1016\/S0140-6736(11)60830-1.","journal-title":"Lancet"},{"key":"4016_CR31","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jad.2019.03.055","volume":"251","author":"F Bouckaert","year":"2019","unstructured":"Bouckaert F, Emsell L, Vansteelandt K, De Winter FL, Van den Stock J, Obbels J, et al. Electroconvulsive therapy response in late-life depression unaffected by age-related brain changes. J. Affect. Disord. 2019;251:114\u201320. https:\/\/doi.org\/10.1016\/j.jad.2019.03.055.","journal-title":"J. Affect. Disord"},{"key":"4016_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12991-024-00543-9","volume":"24","author":"Y Takekita","year":"2025","unstructured":"Takekita Y, Suwa T, Yasuda K, Kawashima H, Omori W, Kurimoto N, et al. Approaches for difficult-to-induce-seizures electroconvulsive therapy cases (DEC): a Japanese expert consensus. Ann. Gen. Psychiatry. 2025;24:2. https:\/\/doi.org\/10.1186\/s12991-024-00543-9.","journal-title":"Ann. Gen. Psychiatry"},{"key":"4016_CR33","doi-asserted-by":"publisher","first-page":"607","DOI":"10.2147\/NDT.S160093","volume":"14","author":"H Kawashima","year":"2018","unstructured":"Kawashima H, Kobayashi Y, Suwa T, Murai T, Yoshioka R. Successful switch from bilateral brief pulse to right unilateral ultrabrief pulse electroconvulsive therapy after failure to induce seizures. Neuropsychiatr. Dis. Treat. 2018;14:607\u201310. https:\/\/doi.org\/10.2147\/NDT.S160093.","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"4016_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/YCT.0000000000001031","volume":"41","author":"T Sakayori","year":"2025","unstructured":"Sakayori T, Wada K, Takebayashi M, Ueda S, Machino A, Yoshimura A, et al. Multicenter observational study of electroconvulsive therapy in Japan. J. ECT. 2025;41:31\u20136. https:\/\/doi.org\/10.1097\/YCT.0000000000001031.","journal-title":"J. ECT"},{"key":"4016_CR35","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/YCT.0b013e3181c18a79","volume":"26","author":"M Takebayashi","year":"2010","unstructured":"Takebayashi M. The development of electroconvulsive therapy in Japan. J. ECT. 2010;26:14\u20135. https:\/\/doi.org\/10.1097\/YCT.0b013e3181c18a79.","journal-title":"J. ECT"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04016-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04016-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04016-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T02:39:57Z","timestamp":1779158397000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-026-04016-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4016"],"URL":"https:\/\/doi.org\/10.1038\/s41398-026-04016-3","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"272"}}